appScorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
SeQuent Scientific Ltd
SEQUENT
Price Chart
Scorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
SeQuent Scientific Limited is a holding company that operates in pharmaceutical sector.
Investor PresentationView older
View Older PresentationsPeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent EventsAll events
Annual Secretarial Compliance Report
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please findenclosed Annual Secretarial Compliance Report of Sequent Scientific Limited issued by M/s. NileshShah & Associates, Practicing Company Secretaries, for the year ended March 31, 2023. | Download
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please findenclosed Annual Secretarial Compliance Report of Sequent Scientific Limited issued by M/s. NileshShah & Associates, Practicing Company Secretaries, for the year ended March 31, 2023. | Download
Cash Dividend
Final • Div/Share: ₹ 0.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant